| Ligand-targeted theranostic nanomedicines against cancer VJ Yao, S D'Angelo, KS Butler, C Theron, TL Smith, S Marchiò, ... Journal of Controlled Release 240, 267-286, 2016 | 210 | 2016 |
| Many routes to an antibody heavy-chain CDR3: necessary, yet insufficient, for specific binding S D’Angelo, F Ferrara, L Naranjo, MF Erasmus, P Hraber, ARM Bradbury Frontiers in immunology 9, 336672, 2018 | 95 | 2018 |
| Rapid interactome profiling by massive sequencing R Di Niro, AM Sulic, F Mignone, S D'Angelo, R Bordoni, M Iacono, ... Nucleic acids research 38 (9), e110-e110, 2010 | 83 | 2010 |
| Deep sequencing in library selection projects: what insight does it bring? J Glanville, S D’Angelo, TA Khan, ST Reddy, L Naranjo, F Ferrara, ... Current opinion in structural biology 33, 146-160, 2015 | 79 | 2015 |
| Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo release H Hosoya, AS Dobroff, WHP Driessen, V Cristini, LM Brinker, FI Staquicini, ... Proceedings of the National Academy of Sciences 113 (7), 1877-1882, 2016 | 66 | 2016 |
| The antibody mining toolbox: an open source tool for the rapid analysis of antibody repertoires S D'Angelo, J Glanville, F Ferrara, L Naranjo, CD Gleasner, X Shen, ... MAbs 6 (1), 160-172, 2014 | 54 | 2014 |
| Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer F Ferrara, DI Staquicini, WHP Driessen, S D’Angelo, AS Dobroff, M Barry, ... Proceedings of the National Academy of Sciences 113 (45), 12786-12791, 2016 | 53 | 2016 |
| Recombinant renewable polyclonal antibodies F Ferrara, S D’Angelo, T Gaiotto, L Naranjo, H Tian, S Gräslund, ... MAbs 7 (1), 32-41, 2015 | 51 | 2015 |
| From deep sequencing to actual clones S D'Angelo, S Kumar, L Naranjo, F Ferrara, C Kiss, ARM Bradbury Protein Engineering, Design & Selection 27 (10), 301-307, 2014 | 49 | 2014 |
| A comprehensive analysis of filamentous phage display vectors for cytoplasmic proteins: an analysis with different fluorescent proteins N Velappan, HE Fisher, E Pesavento, L Chasteen, S D'Angelo, C Kiss, ... Nucleic acids research 38 (4), e22-e22, 2010 | 41 | 2010 |
| Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes AS Dobroff, S D’Angelo, BL Eckhardt, F Ferrara, DI Staquicini, ... Proceedings of the National Academy of Sciences 113 (45), 12780-12785, 2016 | 36 | 2016 |
| Antibody library selection by the β-lactamase protein fragment complementation assay P Secco, E D'Agostini, R Marzari, M Licciulli, R Di Niro, S D'Angelo, ... Protein Engineering, Design & Selection 22 (3), 149-158, 2009 | 33 | 2009 |
| Therapeutic targeting of membrane-associated GRP78 in leukemia and lymphoma: preclinical efficacy in vitro and formal toxicity study of BMTP-78 in rodents and primates DI Staquicini, S D'Angelo, F Ferrara, K Karjalainen, G Sharma, TL Smith, ... The pharmacogenomics journal 18 (3), 436-443, 2018 | 29 | 2018 |
| Profiling celiac disease antibody repertoire S D'Angelo, F Mignone, C Deantonio, R Di Niro, R Bordoni, R Marzari, ... Clinical Immunology 148 (1), 99-109, 2013 | 29 | 2013 |
| Filtering "genic" open reading frames from genomic DNA samples for advanced annotation S D'Angelo, N Velappan, F Mignone, C Santoro, D Sblattero, C Kiss, ... BMC genomics 12 (Suppl 1), S5, 2011 | 29 | 2011 |
| Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody libraries AAR Teixeira, MF Erasmus, S D’Angelo, L Naranjo, F Ferrara, ... MAbs 13 (1), 1980942, 2021 | 26 | 2021 |
| A pandemic-enabled comparison of discovery platforms demonstrates a naïve antibody library can match the best immune-sourced antibodies F Ferrara, MF Erasmus, S D’Angelo, C Leal-Lopes, AA Teixeira, ... Nature communications 13 (1), 462, 2022 | 25 | 2022 |
| Autoantibodies against the cell surface–associated chaperone GRP78 stimulate tumor growth via tissue factor AA Al-Hashimi, P Lebeau, F Majeed, E Polena, Š Lhotak, CAF Collins, ... Journal of Biological Chemistry 292 (51), 21180-21192, 2017 | 24 | 2017 |
| A single donor is sufficient to produce a highly functional in vitro antibody library MF Erasmus, S D’Angelo, F Ferrara, L Naranjo, AA Teixeira, R Buonpane, ... Communications Biology 4 (1), 350, 2021 | 20 | 2021 |
| Human immunodeficiency viruses pseudotyped with SARS-CoV-2 spike proteins infect a broad spectrum of human cell lines through multiple entry mechanisms C Xu, A Wang, K Geng, W Honnen, X Wang, N Bruiners, S Singh, ... Viruses 13 (6), 953, 2021 | 18 | 2021 |
